参考文献 References
[1] 侯思浩,周毅,乳腺癌导管相关性血栓研究进展. 安徽医,2023,27(2):230-235.
[2] 王浩,侯朝铭,高静等,中国乳腺癌患者静脉血栓危险因素Meta分析.河南外科学杂志,2023,29(01):22-27.
[3] 李静,强万敏,张方圆等.构建乳腺癌患者静脉血栓栓塞症风险预测模型. 护理研究,2020,34(16):2852-2857.
[4] 李慧妍邵群张志仁导管相关性血栓研究进展.肿瘤综合治疗电子杂志,2019,5(03):8-12.
[5] KUCHER, NILS. Deep-vein thrombosis of the upper extremities[J]. N Engl J Med,2011, 364(9):861-869.
[6] DEBOURDEAU P, ESPIÉ M, CHEVRET S, et al. Incidence, risk factors, and outcomes of central venous catheter-related thromboembolism in breast cancer patients: the CAVECCAS study[J]. Cancer Med,2017,6(11):2732-2744.
[7] 石果,罗凤,张玲; 172例乳腺癌输液港静脉血栓相关因素分析.重庆医科大学学报,2016,41(05):530-532.
[8] 苏泽隆李文玲陈浩鑫等乳腺癌化疗病人PICC相关性静脉血栓危险因素分析.广东医学,2022,43(12):1569-1572.
[9] 王德光,谭春玲,王洪燕等乳腺癌深静脉静脉血栓栓塞症危险因素的Meta分析.中国现代普通外科进展,2022, 25(06):444-450.
[10] LEE AYY, LEVINE MN, BUTLER G, et al. Incidence, risk factors, and outcomes of catheter-related thrombosis in adult patients with cancer[J]. J Clin Oncol,2006,24(9): 1404-1408.
[11] Schears G J , Ferko N , Syed I ,et al. Peripherally inserted central catheters inserted with current best practices have low deep vein thrombosis and central line–associated bloodstream infection risk compared with centrally inserted central catheters: A contemporary meta-analysis:[J].The Journal of Vascular Access, 2021, 22(1):9-25.
[12] 刘利,张旭,刘晓玲癌症患者PICC导管相关性静脉血栓危险因素及风险评估研究进展.全科护理,2022, 20(30): 4222-4225.
[13] 张欣,朱玉欣,高亚伟等不同材质和结构导管对肿瘤病人PICC置管后血栓形成的影响.河北医药,2021, 43(05): 684-687+692.
[14] CHOPRA V, ANAND S, HICKNER A, et al. Risk of venous thromboembolism associated with peripherally inserted central catheters: a systematic review and meta-analysis[J]. Lancet,2013,382(9889):311-325.
[15] MA L, LIU YP, WANG JX, et al. Totally implantable venous accessport systems and associated complications: a single-institution retrospective analysis of 2 996 breast cancer patients[J]. MolClin Oncol,2016,4(3):456-460.
[16] Razouki ZA, Ali NT, Nguyen VQ, Escalante CP. Risk factors associated with venous thromboembolism in breast cancer: a narrative review[J]. Support Care Cancer. 2022;30(10):8589-8597.
[17] 王德光,王洪燕,谭春玲,等.乳腺癌患者发生静脉血栓栓塞症危险因素分析[J].创伤与急危重病医学,2021,9(02): 116-119.
[18] GAO Y, LIU Y, CHEN W, et al. Peripherally inserted central catheter thrombosis incidence and risk factors in cancer patients:a double-center prospective investigation[J]. Ther Clin Risk Manag, 2015, 11:153-160.
[19] 娄幼幼,林娇,王玉玲乳腺癌化疗患者输液,并发血栓的危险因素及应对措施.医院管理论坛,2020,37(10):35-37.
[20] Previtali E, Bucciarelli P, Passamonti SM, et al.Risk factors for venous and arterial thrombosis[J]. Blood Transfus. 2011;9(2):120-138.
[21] Nolan L, Darby A, Boleti K,et al.The incidence of symptomatic thromboembolism in patients receiving adjuvant anthracycline-based chemotherapy for early stage breast cancer [J]. Breast. 2011;20(2):151-154.
[22] 吴坤,蔡永兰. PICC静脉血栓形成原因分析及护理[J]. 中国社区医师(医学专业),2012,14(2):353-354.